Increased susceptibility of airway epithelial cells from ataxia-telangiectasia to S. pneumoniae infection due to oxidative damage and impaired innate immunity

Abrey J Yeo, Anna Henningham, Emmanuelle Fantino, Sally Galbraith, Lutz Krause, Claire E Wainwright, Peter D Sly, Martin F Lavin, Abrey J Yeo, Anna Henningham, Emmanuelle Fantino, Sally Galbraith, Lutz Krause, Claire E Wainwright, Peter D Sly, Martin F Lavin

Abstract

Respiratory disease is a major cause of morbidity and mortality in patients with ataxia-telangiectasia (A-T) who are prone to recurrent sinopulmonary infections, bronchiectasis, pulmonary fibrosis, and pulmonary failure. Upper airway infections are common in patients and S. pneumoniae is associated with these infections. We demonstrate here that the upper airway microbiome in patients with A-T is different from that to healthy controls, with S. pneumoniae detected largely in patients only. Patient-specific airway epithelial cells and differentiated air-liquid interface cultures derived from these were hypersensitive to infection which was at least in part due to oxidative damage since it was partially reversed by catalase. We also observed increased levels of the pro-inflammatory cytokines IL-8 and TNF-α (inflammasome-independent) and a decreased level of the inflammasome-dependent cytokine IL-β in patient cells. Further investigation revealed that the ASC-Caspase 1 signalling pathway was defective in A-T airway epithelial cells. These data suggest that the heightened susceptibility of these cells to S. pneumoniae infection is due to both increased oxidative damage and a defect in inflammasome activation, and has implications for lung disease in these patients.

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Difference in microbial profile of upper respiratory tracts between healthy controls and patients with A-T. 16S rDNA sequencing from nasal swabs obtained from patients with A-T (n = 10) and healthy controls (n = 10). (A) Distribution of the 20 most abundant bacterial families found in A-T and controls. (B) Rank test plot showed no significant differences (Anova p = 0.14) at this level in the Streptococceae family between A-T and controls. (C) PCR analysis revealed the presence of S. pneumoniae in all A-T samples. RFU; relative fluorescence units. (D) Multivariate analysis using canonical correlation analysis (CCA) showed distinct clustering of microbial populations between patients with A-T and healthy controls (p = 0.034).
Figure 2
Figure 2
Increased sensitivity in A-T airway epithelial cells to S. pneumoniae infection. (A) Percentage of cell death induced by S. pneumoniae infection in control and A-T cells in the presence or absence of catalase (cat). Unpaired, two-tailed Mann-Whitney tests were carried out. *p < 0.03 between control and A-T at 8 h, and A-T and A-T + cat at 8 h. (B,C) Increase in inflammasome-independent pro-inflammatory cytokines IL-8 and TNF-α respectively in A-T as compared to control cells. Co-culture with catalase (cat) decreased this response. (D) Decrease in inflammasome-dependent cytokine IL-1β in A-T as compared to control cells, suggesting a defect in inflammasome activation. A-T n = 7, healthy controls n = 7. All data were plotted as the mean ± s.d. Kruskal-Wallis tests were performed and when significant (p < 0.05), Mann-Whitney tests were carried out. ns; not significant, *p < 0.03.
Figure 3
Figure 3
Increased sensitivity in A-T air-liquid interface cultures to S. pneumoniae infection. (A) Immunostaining of individual cell types in differentiated epithelia at ALI. Left panel: goblet cells (MUC5B; green), tight junctions (ZO-1; red); right panel: basal cells (cytokeratin 14; green) and ciliated epithelial cells (Ac α-tubulin; red). (B) Disruption of the respiratory epithelia at ALI by 24 h was observed in A-T but not in controls. (C) Percentage of cell death induced by S. pneumonia infection in control and A-T cells. (D) Transepithelial electrical resistance (TEER) reading performed on control and A-T ALI cultures post-infection. A-T n = 3, healthy controls n = 3. Unpaired, two-tailed Mann-Whitney tests were carried out. p < 0.03 between control and A-T at 48 h. All data were plotted as the mean ± s.d.
Figure 4
Figure 4
Increase in pro-inflammatory cytokines in A-T ALI cultures post-infection. (A,B) Increase in inflammasome-independent pro-inflammatory cytokines IL-8 and TNF-α in A-T as compared to control cells respectively. (C) Decrease in inflammasome-dependent cytokine IL-1β in A-T as compared to control cells, suggesting a defect in inflammasome activation. A-T n = 3, healthy controls n = 3. All data were plotted as the mean ± s.d. Unpaired, two-tailed Mann-Whitney tests were carried out. ns; not significant, *p < 0.03.
Figure 5
Figure 5
Loss of ATM impairs inflammasome activation following S. pneumoniae infection. (A) Immunostaining for caspase-1 (green) and ASC (red) showed evidence of inflammasome activation in control cells following infection with S. pneumoniae. In contrast, reduced levels of Caspase-1 and ASC specks were observed in A-T cells post-infection, suggesting a defect in inflammasome assembly. (B) Quantitation of Caspase-1-ASC foci formation in airway epithelial cells from healthy controls and patients with A-T. A-T n = 3, healthy controls n = 3. Experiment was performed in triplicates with a minimum of 200 cells per experiment counted for Caspase-1 and ASC foci. All data were plotted as the mean ± s.d. Unpaired, two-tailed Mann-Whitney test was performed, *p < 0.05.

References

    1. Lavin MF, et al. Therapeutic targets and investigated treatments for Ataxia-Telangiectasia. Expert Opin Orphan D. 2016;4:1263–1276. doi: 10.1080/21678707.2016.1254618.
    1. Rothblum-Oviatt C, et al. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11:159. doi: 10.1186/s13023-016-0543-7.
    1. Boder E. Ataxia-telangiectasia: an overview. Kroc Found Ser. 1985;19:1–63.
    1. Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol. 2008;9:759–769. doi: 10.1038/nrm2514.
    1. Bhatt JM, Bush A. Microbiological surveillance in lung disease in ataxia telangiectasia. Eur Respir J. 2014;43:1797–1801. doi: 10.1183/09031936.00141413.
    1. Bott L, et al. Lung disease in ataxia-telangiectasia. Acta Paediatr. 2007;96:1021–1024. doi: 10.1111/j.1651-2227.2007.00338.x.
    1. McGrath-Morrow SA, et al. Elevated serum IL-8 levels in ataxia telangiectasia. J Pediatr. 2010;156:682–684 e681. doi: 10.1016/j.jpeds.2009.12.007.
    1. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 2004;144:505–511. doi: 10.1016/j.jpeds.2003.12.046.
    1. Schroeder SA, Zielen S. Infections of the respiratory system in patients with ataxia-telangiectasia. Pediatr Pulmonol. 2014;49:389–399. doi: 10.1002/ppul.22817.
    1. Bhatt JM, et al. Ataxia telangiectasia: why should the ERS care? Eur Respir J. 2015;46:1557–1560. doi: 10.1183/13993003.01456-2015.
    1. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003;3:155–168. doi: 10.1038/nrc1011.
    1. Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) 2002;1:3–25. doi: 10.1016/S1568-7864(01)00007-6.
    1. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science. 2010;330:517–521. doi: 10.1126/science.1192912.
    1. Chen P, et al. Oxidative stress is responsible for deficient survival and dendritogenesis in Purkinje neurons from ataxia-telangiectasia mutated mutant mice. J Neurosci. 2003;23:11453–11460. doi: 10.1523/JNEUROSCI.23-36-11453.2003.
    1. Gueven N, et al. Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant. Free Radical Bio Med. 2006;41:992–1000. doi: 10.1016/j.freeradbiomed.2006.06.018.
    1. Barlow C, et al. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci USA. 1999;96:9915–9919. doi: 10.1073/pnas.96.17.9915.
    1. Stewart R, et al. A patient-derived olfactory stem cell disease model for ataxia-telangiectasia. Hum Mol Genet. 2013;22:2495–2509. doi: 10.1093/hmg/ddt101.
    1. Nayler S, et al. Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem Cells Transl Med. 2012;1:523–535. doi: 10.5966/sctm.2012-0024.
    1. Ito K, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004;431:997–1002. doi: 10.1038/nature02989.
    1. Reliene R, Fleming SM, Chesselet MF, Schiestl RH. Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice. Food Chem Toxicol. 2008;46:1371–1377. doi: 10.1016/j.fct.2007.08.028.
    1. Reliene R, Schiestl RH. Antioxidants suppress lymphoma and increase longevity in Atm-deficient mice. J Nutr. 2007;137:229S–232S. doi: 10.1093/jn/137.1.229S.
    1. Rai P, et al. Streptococcus pneumoniae secretes hydrogen peroxide leading to DNA damage and apoptosis in lung cells. Proc Natl Acad Sci USA. 2015;112:E3421–3430. doi: 10.1073/pnas.1424144112.
    1. Yeo AJ, et al. Loss of ATM in Airway Epithelial Cells is Associated with Susceptibility to Oxidative Stress. Am J Respir Crit Care Med. 2017;196:391. doi: 10.1164/rccm.201611-2210LE.
    1. Spann KM, et al. Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy. Thorax. 2014;69:918–925. doi: 10.1136/thoraxjnl-2013-204908.
    1. Berube K, Prytherch Z, Job C, Hughes T. Human primary bronchial lung cell constructs: the new respiratory models. Toxicology. 2010;278:311–318. doi: 10.1016/j.tox.2010.04.004.
    1. Alfonso-Prieto M, Biarnes X, Vidossich P, Rovira C. The molecular mechanism of the catalase reaction. J Am Chem Soc. 2009;131:11751–11761. doi: 10.1021/ja9018572.
    1. McGrath-Morrow SA, Collaco JM, Detrick B, Lederman HM. Serum Interleukin-6 Levels and Pulmonary Function in Ataxia-Telangiectasia. J Pediatr. 2016;171:256–261 e251. doi: 10.1016/j.jpeds.2016.01.002.
    1. Sutterwala FS, et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006;24:317–327. doi: 10.1016/j.immuni.2006.02.004.
    1. Raupach B, Peuschel SK, Monack DM, Zychlinsky A. Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection. Infect Immun. 2006;74:4922–4926. doi: 10.1128/IAI.00417-06.
    1. Sahoo M, Ceballos-Olvera I, del Barrio L, Re F. Role of the inflammasome, IL-1beta, and IL-18 in bacterial infections. ScientificWorldJournal. 2011;11:2037–2050. doi: 10.1100/2011/212680.
    1. Mayer-Barber KD, Yan B. Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell Mol Immunol. 2017;14:22–35. doi: 10.1038/cmi.2016.25.
    1. Bragonzi A, Copreni E, de Bentzmann S, Ulrich M, Conese M. Airway epithelial cell-pathogen interactions. J Cyst Fibros. 2004;3(2):197–201. doi: 10.1016/j.jcf.2004.05.041.
    1. Gomez MI, Prince A. Airway epithelial cell signaling in response to bacterial pathogens. Pediatr Pulmonol. 2008;43:11–19. doi: 10.1002/ppul.20735.
    1. Hill DB, Button B. Establishment of respiratory air-liquid interface cultures and their use in studying mucin production, secretion, and function. Methods Mol Biol. 2012;842:245–258. doi: 10.1007/978-1-61779-513-8_15.
    1. Muller, L., Brighton, L. E., Carson, J. L., Fischer, W. A. & Jaspers, I. Culturing of Human Nasal Epithelial Cells at the Air Liquid Interface. Jove-J Vis Exp, UNSP e50646, 10.3791/50646 (2013).
    1. Rock JR, Randell SH, Hogan BLM. Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech. 2010;3:545–556. doi: 10.1242/dmm.006031.
    1. Erttmann SF, et al. Loss of the DNA Damage Repair Kinase ATM Impairs Inflammasome-Dependent Anti-Bacterial Innate Immunity. Immunity. 2016;45:106–118. doi: 10.1016/j.immuni.2016.06.018.
    1. Morales, A. J. et al. A type I IFN-dependent DNA damage response regulates the genetic program and inflammasome activation in macrophages. Elife6, ARTN e24655, 10.7554/eLife.24655 (2017).
    1. Hu B, et al. The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury. Science. 2016;354:765–768. doi: 10.1126/science.aaf7532.
    1. McGrath-Morrow SA, et al. Evaluation and management of pulmonary disease in ataxia-telangiectasia. Pediatr Pulmonol. 2010;45:847–859. doi: 10.1002/ppul.21277.
    1. Schroeder SA, Swift M, Sandoval C, Langston C. Interstitial lung disease in patients with ataxia-telangiectasia. Pediatr Pulmonol. 2005;39:537–543. doi: 10.1002/ppul.20209.
    1. Vareille M, Kieninger E, Edwards MR, Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev. 2011;24:210–229. doi: 10.1128/CMR.00014-10.
    1. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J. 2004;23:327–333. doi: 10.1183/09031936.03.00098803.
    1. Siegel SJ, Weiser JN. Mechanisms of Bacterial Colonization of the Respiratory Tract. Annu Rev Microbiol. 2015;69:425–444. doi: 10.1146/annurev-micro-091014-104209.
    1. Boutin S, Dalpke AH. Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients. Mol Cell Pediatr. 2017;4:1. doi: 10.1186/s40348-016-0067-1.
    1. Baturcam E, et al. Human Metapneumovirus Impairs Apoptosis of Nasal Epithelial Cells in Asthma via HSP70. Journal of innate immunity. 2017;9:52–64. doi: 10.1159/000449101.
    1. Beale, J. et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Science translational medicine6, 256ra134, 10.1126/scitranslmed.3009124 (2014).
    1. Kicic A, et al. Impaired airway epithelial cell responses from children with asthma to rhinoviral infection. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2016;46:1441–1455. doi: 10.1111/cea.12767.
    1. Al-Sayed AA, Agu RU, Massoud E. Models for the study of nasal and sinus physiology in health and disease: A review of the literature. Laryngoscope Investig Otolaryngol. 2017;2:398–409. doi: 10.1002/lio2.117.
    1. Morris MC, Pichichero ME. Streptococcus pneumoniae burden and nasopharyngeal inflammation during acute otitis media. Innate Immun. 2017;23:667–677. doi: 10.1177/1753425917737825.
    1. Fang R, et al. Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J Immunol. 2011;187:4890–4899. doi: 10.4049/jimmunol.1100381.
    1. Zakrzewski M, et al. Calypso: a user-friendly web-server for mining and visualizing microbiome-environment interactions. Bioinformatics. 2017;33:782–783. doi: 10.1093/bioinformatics/btw725.
    1. Yeo AJ, et al. Senataxin controls meiotic silencing through ATR activation and chromatin remodeling. Cell Discov. 2015;1:15025. doi: 10.1038/celldisc.2015.25.

Source: PubMed

3
Tilaa